Latest Breaking News On - Genomics company profile - Page 3 : comparemela.com

10x Genomics, Inc (NASDAQ:TXG) Given Average Rating of Moderate Buy by Brokerages

10x Genomics, Inc (NASDAQ:TXG) Given Average Rating of Moderate Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesSerge saxonovAsia pacificBenjaminj hindsonStifel nicolausSecurities exchange commissionGenomics company profileAssociates corpGenomics incWolfe researchFinancial services group incAtlas capital advisorsComerica bankGet free reportMarketbeat ratingsGenomics trading down

Trexquant Investment LP Boosts Stake in 10x Genomics, Inc (NASDAQ:TXG)

Trexquant Investment LP Boosts Stake in 10x Genomics, Inc (NASDAQ:TXG)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesAsia pacificJustinj mcanearStifel nicolausSerge saxonovGenomics company profileHussman strategic advisors incPrimecap management coTd asset management incCharles schwab investment management incWolfe researchExchange commissionMirae asset global investments coGenomics incTrexquant investmentFree report

Aigen Investment Management LP Makes New Investment in 10x Genomics, Inc (NASDAQ:TXG)

Aigen Investment Management LP acquired a new stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 18,521 shares of the company’s stock, valued at approximately $764,000. Other hedge funds also recently modified their holdings of the […]

United statesJames wilburStifel nicolausSerge saxonovAsia pacificCitigroup incEnvestnet asset management incInvesco ltdWolfe researchGenomics incGenomics company profileSecurities exchange commissionAigen investment managementFree reportAsset managementExchange commission

Insider Selling: 10x Genomics, Inc (NASDAQ:TXG) CEO Sells $49,530 00 in Stock

10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) CEO Serge Saxonov sold 1,000 shares of 10x Genomics stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $49.53, for a total transaction of $49,530.00. Following the completion of the sale, the chief executive officer now owns […]

United statesAsia pacificSerge saxonovWolfe researchGenomics incVanguard group incGenomics company profileSecurities exchange commissionBlackrock incInvestment managementSands capital managementGet free reportExchange commissionGenomics trading downCapital managementGenomics company

10x Genomics, Inc (NASDAQ:TXG) Sees Significant Increase in Short Interest

10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 6,660,000 shares, a growth of 16.4% from the January 15th total of 5,720,000 shares. Based on an average daily volume of 1,160,000 shares, […]

United statesAsia pacificJames wilburSerge saxonovAtlas capital advisorsBarclays plcGroup plcGenomics incSecurities exchange commissionGenomics company profileWolfe researchGet free reportExchange commissionEmployees retirement systemRetirement systemGeneral group plc